DOCSLIB.ORG

Ca 2+ -Dependent Transcriptional Repressors KCNIP and Regulation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Ca 2+ -Dependent Transcriptional Repressors KCNIP and Regulation of Prognosis Genes in Glioblastoma Isabelle Néant, Jacques Haiech, Marie-Claude Kilhoffer, Francisco Aulestia, Marc Moreau, Catherine Leclerc To cite this version: Isabelle Néant, Jacques Haiech, Marie-Claude Kilhoffer, Francisco Aulestia, Marc Moreau, et al.. Ca 2+ -Dependent Transcriptional Repressors KCNIP and Regulation of Prognosis Genes in Glioblas- toma. Frontiers in Molecular Neuroscience, Frontiers Media, 2018, 10.3389/fnmol.2018.00472. hal- 02329159 HAL Id: hal-02329159 https://hal.archives-ouvertes.fr/hal-02329159 Submitted on 23 Oct 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. fnmol-11-00472 December 16, 2018 Time: 13:6 # 1 REVIEW published: 18 December 2018 doi: 10.3389/fnmol.2018.00472 Ca2C-Dependent Transcriptional Repressors KCNIP and Regulation of Prognosis Genes in Glioblastoma Isabelle Néant1, Jacques Haiech2, Marie-Claude Kilhoffer2, Francisco J. Aulestia3, Marc Moreau1 and Catherine Leclerc1* 1 Centre de Biologie du Développement (CBD), Centre de Biologie Intégrative (CBI), CNRS, UPS, Université de Toulouse, Toulouse, France, 2 Laboratoire d’Excellence Medalis, CNRS, LIT UMR 7200, Université de Strasbourg, Strasbourg, France, 3 Department of Basic Science and Craniofacial Biology, NYU College of Dentistry, New York, NY, United States Glioblastomas (GBMs) are the most aggressive and lethal primary astrocytic tumors in adults, with very poor prognosis. Recurrence in GBM is attributed to glioblastoma stem-like cells (GSLCs). The behavior of the tumor, including proliferation, progression, invasion, and significant resistance to therapies, is a consequence of the self-renewing properties of the GSLCs, and their high resistance to chemotherapies have been attributed to their capacity to enter quiescence. Thus, targeting GSLCs may constitute Edited by: one of the possible therapeutic challenges to significantly improve anti-cancer treatment Jose R. Naranjo, 2C Spanish National Research Council regimens for GBM. Ca signaling is an important regulator of tumorigenesis in (CSIC), Spain GBM, and the transition from proliferation to quiescence involves the modification Reviewed by: of the kinetics of Ca2C influx through store-operated channels due to an increased Ana Cristina Calvo, capacity of the mitochondria of quiescent GSLC to capture Ca2C. Therefore, the Universidad de Zaragoza, Spain Marisa Brini, identification of new therapeutic targets requires the analysis of the calcium-regulated Università degli Studi di Padova, Italy elements at transcriptional levels. In this review, we focus onto the direct regulation of Mario Vallejo, Instituto de Investigaciones gene expression by KCNIP proteins (KCNIP1–4). These proteins constitute the class Biomédicas Alberto Sols (IIBM), Spain E of Ca2C sensor family with four EF-hand Ca2C-binding motifs and control gene *Correspondence: transcription directly by binding, via a Ca2C-dependent mechanism, to specific DNA Catherine Leclerc sites on target genes, called downstream regulatory element (DRE). The presence of [email protected] putative DRE sites on genes associated with unfavorable outcome for GBM patients Received: 03 October 2018 suggests that KCNIP proteins may contribute to the alteration of the expression of Accepted: 04 December 2018 Published: 18 December 2018 these prognosis genes. Indeed, in GBM, KCNIP2 expression appears to be significantly Citation: linked to the overall survival of patients. In this review, we summarize the current 2C Néant I, Haiech J, Kilhoffer M-C, knowledge regarding the quiescent GSLCs with respect to Ca signaling and discuss Aulestia FJ, Moreau M and Leclerc C how Ca2C via KCNIP proteins may affect prognosis genes expression in GBM. This (2018) Ca2C-Dependent Transcriptional Repressors KCNIP original mechanism may constitute the basis of the development of new therapeutic and Regulation of Prognosis Genes strategies. in Glioblastoma. Front. Mol. Neurosci. 11:472. Keywords: Ca2C signaling, neuronal Ca2C sensors, KCNIP, glioblastoma multiform, cancer stem cells (CSC), doi: 10.3389/fnmol.2018.00472 quiescence Frontiers in Molecular Neuroscience| www.frontiersin.org 1 December 2018| Volume 11| Article 472 fnmol-11-00472 December 16, 2018 Time: 13:6 # 2 Néant et al. KCNIP Ca2C Sensors and Glioblastoma INTRODUCTION (SOCE) (Dong et al., 2017). These data exemplify the fact that Ca2C channels, pumps, and exchangers may represent potential Among tumors of the central nervous system, glioblastomas therapeutic targets. In this review, we will summarize the current (GBMs) are the most aggressive and lethal primary astrocytic knowledge regarding the quiescent GSLCs with respect to Ca2C tumors in adults, with very poor prognosis (Louis et al., signaling and describe an original mechanism by which Ca2C can 2016; Lapointe et al., 2018). More than 90% of the patients activate some genes involved in the prognosis of GBM in order show recurrence after therapies combining surgical resection, to propose new strategies to explore the molecular basis of GBM radiotherapy, and temozolomide (TMZ)-based chemotherapy, development for therapeutic issues. and the mean survival period rarely exceeds 2 years (Stupp et al., 2005). According to the cancer stem cell model, recurrence in GBM is attributed to a small sub-population of tumor cells called TRANSITION FROM PROLIFERATION TO glioblastoma stem-like cells (GSLCs). These GSLCs have stem- QUIESCENCE AND Ca2C SIGNALING like properties and are responsible for the initiation and the growth of the tumors (Visvader and Lindeman, 2008). Indeed, Quiescent cells are non-proliferative cells, arrested in a specific the GSLCs provide all the subtypes of cells that comprise the phase of the cell cycle called G0 (Coller et al., 2006). Quiescence tumor including some pseudo-endothelial cells (Ricci-Vitiani is not a prolonged G1 phase and in contrary to the cell- et al., 2010). GSLCs are characterized by a molecular signature cycle arrest observed in differentiation or senescence, it is which combines markers of neural and/or embryonic stem reversible. Transcriptional profiling data reveal that quiescent cells and of mesenchymal cells. Numerous studies support the stem cells are characterized by a common set of genes which proposal that the behavior of the tumor, including proliferation, are either downregulated, these are genes associated with progression, invasion, and significant resistance to therapies, cell-cycle progression (i.e., CCNA2, CCNB1, and CCNE2), or is determined by the self-renewing properties of the GSLCs upregulated and classified as tumor suppressors, including the (Stupp et al., 2005; Bao et al., 2006; Hegi et al., 2006; Stupp cyclin-dependent kinase inhibitor p21 (CDKN1A) and the G0/G1 and Hegi, 2007; Murat et al., 2008). More importantly, this high switch gene 2 (G0S2)(Yamada et al., 2012; Cheung and Rando, resistance capacity to TMZ treatment have been attributed to 2013). Quiescence represents a strategy for GSLCs to evade slow cycling or relatively quiescent GSLCs (Pistollato et al., 2010; killing. It is thus vital to better characterize the quiescent Deleyrolle et al., 2011). Quiescent GSLCs have been identified GSLCs and to understand the mechanisms involved in the in vivo in a mouse model of GBM (Chen et al., 2012) and transition from a proliferative to a quiescence state. Quiescence in human GBM tumors (Ishii et al., 2016). Thus, targeting is actively regulated by signals provided by the stem cell GSLCs and their stem cell-like properties may constitute one microenvironment. In GBM, quiescent cells are found close to of the possible therapeutic challenges to significantly improve necrotic tissues, in specific niches characterized by a hypoxic anti-cancer treatment regimens for GBM. (Pistollato et al., 2010; Persano et al., 2011; Ishii et al., 2016) and Ca2C is a crucial second messenger (Carafoli and Krebs, acidic microenvironment (Garcia-Martin et al., 2006; Honasoge 2016) that controls a wide variety of cell functions from cell et al., 2014). proliferation and apoptosis to organogenesis (Berridge et al., A recent study suggests that Ca2C is an important regulator 2000; Machaca, 2011; Moreau et al., 2016). Thus, the intracellular of the balance between quiescence and proliferation in Ca2C concentration ([Ca2C]i) is tightly regulated and involves hematopoietic stem cell (HSC) (Umemoto et al., 2018). In Ca2C channels, pumps, and exchangers both at the plasma HSCs, re-entry into cell-cycle requires Ca2C influx through membrane and at the membrane of endoplasmic reticulum, Cav1 voltage-dependent Ca2C channel and the resultant mitochondria, or Golgi apparatus (Bootman, 2012; Humeau activation of mitochondria. Recent findings in our group et al., 2018). In addition, changes in [Ca2C]i do not proceed showed that Ca2C signaling is also required for GBM stem cells in a stereotypical manner. The Ca2C signal can be described quiescence. On GSLCs lines, established from surgical resections by its amplitude (variations of [Ca2C]i levels) and by its
Recommended publications
  • Bivariate Genome-Wide Association Analysis of the Growth and Intake Components of Feed Efficiency

    Bivariate Genome-Wide Association Analysis of the Growth and Intake Components of Feed Efficiency

    Bivariate Genome-Wide Association Analysis of the Growth and Intake Components of Feed Efficiency Nick V. L. Sera˜o1., Dianelys Gonza´lez-Pen˜ a1., Jonathan E. Beever1, Germa´n A. Bollero2, Bruce R. Southey1, Daniel B. Faulkner1, Sandra L. Rodriguez-Zas1,3,4* 1 Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America, 2 Department of Crop Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America, 3 Department of Statistics, University of Illinois at Urbana-Champaign, Champaign, Illinois, United States of America, 4 Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America Abstract Single nucleotide polymorphisms (SNPs) associated with average daily gain (ADG) and dry matter intake (DMI), two major components of feed efficiency in cattle, were identified in a genome-wide association study (GWAS). Uni- and multi-SNP models were used to describe feed efficiency in a training data set and the results were confirmed in a validation data set. Results from the univariate and bivariate analyses of ADG and DMI, adjusted by the feedlot beef steer maintenance requirements, were compared. The bivariate uni-SNP analysis identified (P-value ,0.0001) 11 SNPs, meanwhile the univariate analyses of ADG and DMI identified 8 and 9 SNPs, respectively. Among the six SNPs confirmed in the validation data set, five SNPs were mapped to KDELC2, PHOX2A, and TMEM40. Findings from the uni-SNP models were used to develop highly accurate predictive multi-SNP models in the training data set. Despite the substantially smaller size of the validation data set, the training multi-SNP models had slightly lower predictive ability when applied to the validation data set.
  • Spatially Heterogeneous Choroid Plexus Transcriptomes Encode Positional Identity and Contribute to Regional CSF Production

    Spatially Heterogeneous Choroid Plexus Transcriptomes Encode Positional Identity and Contribute to Regional CSF Production

    The Journal of Neuroscience, March 25, 2015 • 35(12):4903–4916 • 4903 Development/Plasticity/Repair Spatially Heterogeneous Choroid Plexus Transcriptomes Encode Positional Identity and Contribute to Regional CSF Production Melody P. Lun,1,3 XMatthew B. Johnson,2 Kevin G. Broadbelt,1 Momoko Watanabe,4 Young-jin Kang,4 Kevin F. Chau,1 Mark W. Springel,1 Alexandra Malesz,1 Andre´ M.M. Sousa,5 XMihovil Pletikos,5 XTais Adelita,1,6 Monica L. Calicchio,1 Yong Zhang,7 Michael J. Holtzman,7 Hart G.W. Lidov,1 XNenad Sestan,5 Hanno Steen,1 XEdwin S. Monuki,4 and Maria K. Lehtinen1 1Department of Pathology, and 2Division of Genetics, Boston Children’s Hospital, Boston, Massachusetts 02115, 3Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, 4Department of Pathology and Laboratory Medicine, University of California Irvine School of Medicine, Irvine, California 92697, 5Department of Neurobiology and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, Connecticut 06510, 6Department of Biochemistry, Federal University of Sa˜o Paulo, Sa˜o Paulo 04039, Brazil, and 7Pulmonary and Critical Care Medicine, Department of Medicine, Washington University, St Louis, Missouri 63110 A sheet of choroid plexus epithelial cells extends into each cerebral ventricle and secretes signaling factors into the CSF. To evaluate whether differences in the CSF proteome across ventricles arise, in part, from regional differences in choroid plexus gene expression, we defined the transcriptome of lateral ventricle (telencephalic) versus fourth ventricle (hindbrain) choroid plexus. We find that positional identitiesofmouse,macaque,andhumanchoroidplexiderivefromgeneexpressiondomainsthatparalleltheiraxialtissuesoforigin.We thenshowthatmolecularheterogeneitybetweentelencephalicandhindbrainchoroidplexicontributestoregion-specific,age-dependent protein secretion in vitro.
  • Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)

    Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)

    BRIEF COMMUNICATION www.jasn.org Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron Camille Ansermet,* Matthias B. Moor,* Gabriel Centeno,* Muriel Auberson,* † † ‡ Dorothy Zhang Hu, Roland Baron, Svetlana Nikolaeva,* Barbara Haenzi,* | Natalya Katanaeva,* Ivan Gautschi,* Vladimir Katanaev,*§ Samuel Rotman, Robert Koesters,¶ †† Laurent Schild,* Sylvain Pradervand,** Olivier Bonny,* and Dmitri Firsov* BRIEF COMMUNICATION *Department of Pharmacology and Toxicology and **Genomic Technologies Facility, University of Lausanne, Lausanne, Switzerland; †Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts; ‡Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia; §School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia; |Services of Pathology and ††Nephrology, Department of Medicine, University Hospital of Lausanne, Lausanne, Switzerland; and ¶Université Pierre et Marie Curie, Paris, France ABSTRACT Tight control of extracellular and intracellular inorganic phosphate (Pi) levels is crit- leaves.4 Most recently, Legati et al. have ical to most biochemical and physiologic processes. Urinary Pi is freely filtered at the shown an association between genetic kidney glomerulus and is reabsorbed in the renal tubule by the action of the apical polymorphisms in Xpr1 and primary fa- sodium-dependent phosphate transporters, NaPi-IIa/NaPi-IIc/Pit2. However, the milial brain calcification disorder.5 How- molecular identity of the protein(s) participating in the basolateral Pi efflux remains ever, the role of XPR1 in the maintenance unknown. Evidence has suggested that xenotropic and polytropic retroviral recep- of Pi homeostasis remains unknown. Here, tor 1 (XPR1) might be involved in this process. Here, we show that conditional in- we addressed this issue in mice deficient for activation of Xpr1 in the renal tubule in mice resulted in impaired renal Pi Xpr1 in the nephron.
  • Age-Dependent Myocardial Transcriptomic Changes in the Rat

    Age-Dependent Myocardial Transcriptomic Changes in the Rat

    Revista Română de Medicină de Laborator Vol. 22, Nr. 1, Martie, 2014 9 Research article DOI: 10.2478/rrlm-2014-0001 Age-dependent myocardial transcriptomic changes in the rat. Novel insights into atrial and ventricular arrhythmias pathogenesis Modificări transcriptomice dependente de vârstă în miocardul de șobolan. Noi aspecte referitoare la patogeneza aritmiilor atriale și ventriculare Alina Scridon1,2, Emmanuelle Fouilloux-Meugnier3, Emmanuelle Loizon3, Marcel Perian1, Sophie Rome3, Claude Julien2, Christian Barrès2, Philippe Chevalier2,4 1.Physiology Department, University of Medicine and Pharmacy of Tîrgu Mureș, 540139, Tîrgu Mureș, Romania 2. Unité de Neurocardiologie, EA4612, Université Lyon 1, F-69008, Lyon, France 3. Unité 1060 INSERM CarMen, Université Lyon 1, F-69008, Lyon, France 4. Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Rythmologie, 69500, Bron, France Abstract Background: Aging is associated with significantly increased prevalence of cardiac arrhythmias, but tran- scriptional events that underlie this process remain to be established. To gain deeper insight into molecular mech- anisms of aging-related cardiac arrhythmias, we performed mRNA expression analysis comparing atrial and ven- tricular myocardium from Wistar-Kyoto (WKY) rats of different ages. Methods: Atrial and ventricular sampling was performed in 3 groups (n=4 each) of young (14-week-old), adult (25-week-old), and aging (47-week-old) WKY rats. mRNA expressions of 89 genes involved in cardiac arrhythmogenicity were investigated using TaqMan Low Density Array analysis. Results: Of the 89 studied genes, 40 and 64 genes presented steady atrial and ventricu- lar expressions, respectively. All genes differentially expressed within the atria of WKY rats were up-regulated with advancing age, mainly the genes encoding for various K+, Ca2+, Na+ channels, and type 6 collagen.
  • Reversible Cardiac Disease Features in an Inducible CUG Repeat RNA–Expressing Mouse Model of Myotonic Dystrophy

    Reversible Cardiac Disease Features in an Inducible CUG Repeat RNA–Expressing Mouse Model of Myotonic Dystrophy

    Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy Ashish N. Rao, … , Zheng Xia, Thomas A. Cooper JCI Insight. 2021;6(5):e143465. https://doi.org/10.1172/jci.insight.143465. Research Article Cardiology Cell biology Graphical abstract Find the latest version: https://jci.me/143465/pdf RESEARCH ARTICLE Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy Ashish N. Rao,1 Hannah M. Campbell,2,3 Xiangnan Guan,4 Tarah A. Word,2 Xander H.T. Wehrens,2,5 Zheng Xia,4,6 and Thomas A. Cooper1,2,5,7 1Department of Molecular and Cellular Biology, 2Department of Molecular Physiology and Biophysics, and 3Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA. 4Computational Biology Program, Oregon Health & Science University, Portland, Oregon, USA. 5Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas, USA. 6Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA. 7Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA. Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion in the DMPK gene. Expression of pathogenic expanded CUG repeat (CUGexp) RNA causes multisystemic disease by perturbing the functions of RNA-binding proteins, resulting in expression of fetal protein isoforms in adult tissues. Cardiac involvement affects 50% of individuals with DM1 and causes 25% of disease-related deaths. We developed a transgenic mouse model for tetracycline-inducible and heart-specific expression of human DMPK mRNA containing 960 CUG repeats. CUGexp RNA is expressed in atria and ventricles and induced mice exhibit electrophysiological and molecular features of DM1 disease, including cardiac conduction delays, supraventricular arrhythmias, nuclear RNA foci with Muscleblind protein colocalization, and alternative splicing defects.
  • Genome-Wide Association Study of Body Weight

    Genome-Wide Association Study of Body Weight

    Genome-wide association study of body weight in Australian Merino sheep reveals an orthologous region on OAR6 to human and bovine genomic regions affecting height and weight Hawlader A. Al-Mamun, Paul Kwan, Samuel A. Clark, Mohammad H. Ferdosi, Ross Tellam, Cedric Gondro To cite this version: Hawlader A. Al-Mamun, Paul Kwan, Samuel A. Clark, Mohammad H. Ferdosi, Ross Tellam, et al.. Genome-wide association study of body weight in Australian Merino sheep reveals an orthologous region on OAR6 to human and bovine genomic regions affecting height and weight. Genetics Selection Evolution, 2015, 47 (1), pp.66. 10.1186/s12711-015-0142-4. hal-01341302 HAL Id: hal-01341302 https://hal.archives-ouvertes.fr/hal-01341302 Submitted on 4 Jul 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. et al. Genetics Selection Evolution Al-Mamun (2015) 47:66 Genetics DOI 10.1186/s12711-015-0142-4 Selection Evolution RESEARCH ARTICLE Open Access Genome-wide association study of body weight in Australian Merino sheep reveals an orthologous region on OAR6 to human and bovine genomic regions affecting height and weight Hawlader A. Al-Mamun1,2, Paul Kwan2, Samuel A.
  • A Genome-Wide Association Study Identifies Variants in KCNIP4

    A Genome-Wide Association Study Identifies Variants in KCNIP4

    OPEN The Pharmacogenomics Journal (2016) 16, 231–237 © 2016 Macmillan Publishers Limited All rights reserved 1470-269X/16 www.nature.com/tpj ORIGINAL ARTICLE A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough JD Mosley1, CM Shaffer1, SL Van Driest1,2, PE Weeke1,3, QS Wells1, JH Karnes1, DR Velez Edwards4, W-Q Wei5, PL Teixeira5, L Bastarache5, DC Crawford6,RLi7, TA Manolio7, EP Bottinger8, CA McCarty9, JG Linneman10, MH Brilliant10, JA Pacheco11, W Thompson11, RL Chisholm11, GP Jarvik12, DR Crosslin12, DS Carrell13, E Baldwin13, J Ralston13, EB Larson13, J Grafton13, A Scrol13, H Jouni14, IJ Kullo14, G Tromp15, KM Borthwick15, H Kuivaniemi15, DJ Carey15, MD Ritchie16, Y Bradford16, SS Verma16, CG Chute17, A Veluchamy18, MK Siddiqui18, CNA Palmer18, A Doney18, SH MahmoudPour19, AH Maitland-van der Zee19, AD Morris20, JC Denny1,5,21 and DM Roden1,21 The most common side effect of angiotensin-converting enzyme inhibitor (ACEi) drugs is cough. We conducted a genome-wide association study (GWAS) of ACEi-induced cough among 7080 subjects of diverse ancestries in the Electronic Medical Records and Genomics (eMERGE) network. Cases were subjects diagnosed with ACEi-induced cough. Controls were subjects with at least 6 months of ACEi use and no cough. A GWAS (1595 cases and 5485 controls) identified associations on chromosome 4 in an intron of KCNIP4. The strongest association was at rs145489027 (minor allele frequency = 0.33, odds ratio (OR) = 1.3 (95% confidence interval (CI): 1.2–1.4), P = 1.0 × 10 − 8). Replication for six single-nucleotide polymorphisms (SNPs) in KCNIP4 was tested in a second eMERGE population (n = 926) and in the Genetics of Diabetes Audit and Research in Tayside, Scotland (GoDARTS) cohort (n = 4309).
  • Genome-Wide Screening Identifies a KCNIP1 Copy Number Variant As a Genetic Predictor for Atrial Fibrillation

    Genome-Wide Screening Identifies a KCNIP1 Copy Number Variant As a Genetic Predictor for Atrial Fibrillation

    ARTICLE Received 21 Oct 2014 | Accepted 16 Nov 2015 | Published 2 Feb 2016 DOI: 10.1038/ncomms10190 OPEN Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation Chia-Ti Tsai1,2,3, Chia-Shan Hsieh4,5, Sheng-Nan Chang2,3, Eric Y. Chuang4,5, Kwo-Chang Ueng6,7, Chin-Feng Tsai6,7, Tsung-Hsien Lin8, Cho-Kai Wu1, Jen-Kuang Lee1, Lian-Yu Lin1, Yi-Chih Wang1, Chih-Chieh Yu1, Ling-Ping Lai1, Chuen-Den Tseng1, Juey-Jen Hwang1, Fu-Tien Chiang1,9 & Jiunn-Lee Lin1 Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Previous genome- wide association studies had identified single-nucleotide polymorphisms in several genomic regions to be associated with AF. In human genome, copy number variations (CNVs) are known to contribute to disease susceptibility. Using a genome-wide multistage approach to identify AF susceptibility CNVs, we here show a common 4,470-bp diallelic CNV in the first intron of potassium interacting channel 1 gene (KCNIP1) is strongly associated with AF in Taiwanese populations (odds ratio ¼ 2.27 for insertion allele; P ¼ 6.23 Â 10 À 24). KCNIP1 insertion is associated with higher KCNIP1 mRNA expression. KCNIP1-encoded protein potassium interacting channel 1 (KCHIP1) is physically associated with potassium Kv channels and modulates atrial transient outward current in cardiac myocytes. Overexpression of KCNIP1 results in inducible AF in zebrafish. In conclusions, a common CNV in KCNIP1 gene is a genetic predictor of AF risk possibly pointing to a functional pathway. 1 Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, No.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Emerging Roles for Multifunctional Ion Channel Auxiliary Subunits in Cancer T ⁎ Alexander S

    Emerging Roles for Multifunctional Ion Channel Auxiliary Subunits in Cancer T ⁎ Alexander S

    Cell Calcium 80 (2019) 125–140 Contents lists available at ScienceDirect Cell Calcium journal homepage: www.elsevier.com/locate/ceca Emerging roles for multifunctional ion channel auxiliary subunits in cancer T ⁎ Alexander S. Hawortha,b, William J. Brackenburya,b, a Department of Biology, University of York, Heslington, York, YO10 5DD, UK b York Biomedical Research Institute, University of York, Heslington, York, YO10 5DD, UK ARTICLE INFO ABSTRACT Keywords: Several superfamilies of plasma membrane channels which regulate transmembrane ion flux have also been Auxiliary subunit shown to regulate a multitude of cellular processes, including proliferation and migration. Ion channels are Cancer typically multimeric complexes consisting of conducting subunits and auxiliary, non-conducting subunits. Calcium channel Auxiliary subunits modulate the function of conducting subunits and have putative non-conducting roles, further Chloride channel expanding the repertoire of cellular processes governed by ion channel complexes to processes such as trans- Potassium channel cellular adhesion and gene transcription. Given this expansive influence of ion channels on cellular behaviour it Sodium channel is perhaps no surprise that aberrant ion channel expression is a common occurrence in cancer. This review will − focus on the conducting and non-conducting roles of the auxiliary subunits of various Ca2+,K+,Na+ and Cl channels and the burgeoning evidence linking such auxiliary subunits to cancer. Several subunits are upregu- lated (e.g. Cavβ,Cavγ) and downregulated (e.g. Kvβ) in cancer, while other subunits have been functionally implicated as oncogenes (e.g. Navβ1,Cavα2δ1) and tumour suppressor genes (e.g. CLCA2, KCNE2, BKγ1) based on in vivo studies. The strengthening link between ion channel auxiliary subunits and cancer has exposed these subunits as potential biomarkers and therapeutic targets.
  • Containing Interneurons in Hippocampus of a Murine

    Containing Interneurons in Hippocampus of a Murine

    RESEARCH ARTICLE Emergence of non-canonical parvalbumin- containing interneurons in hippocampus of a murine model of type I lissencephaly Tyler G Ekins1,2, Vivek Mahadevan1, Yajun Zhang1, James A D’Amour1,3, Gu¨ lcan Akgu¨ l1, Timothy J Petros1, Chris J McBain1* 1Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States; 2NIH-Brown University Graduate Partnership Program, Providence, United States; 3Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, Bethesda, United States Abstract Type I lissencephaly is a neuronal migration disorder caused by haploinsuffiency of the PAFAH1B1 (mouse: Pafah1b1) gene and is characterized by brain malformation, developmental delays, and epilepsy. Here, we investigate the impact of Pafah1b1 mutation on the cellular migration, morphophysiology, microcircuitry, and transcriptomics of mouse hippocampal CA1 parvalbumin-containing inhibitory interneurons (PV+INTs). We find that WT PV+INTs consist of two physiological subtypes (80% fast-spiking (FS), 20% non-fast-spiking (NFS)) and four morphological subtypes. We find that cell-autonomous mutations within interneurons disrupts morphophysiological development of PV+INTs and results in the emergence of a non-canonical ‘intermediate spiking (IS)’ subset of PV+INTs. We also find that now dominant IS/NFS cells are prone to entering depolarization block, causing them to temporarily lose the ability to initiate action potentials and control network excitation, potentially promoting seizures. Finally, single-cell nuclear RNAsequencing of PV+INTs revealed several misregulated genes related to morphogenesis, cellular excitability, and synapse formation. *For correspondence: [email protected] Competing interests: The Introduction authors declare that no Excitation in neocortical and hippocampal circuits is balanced by a relatively small (10–15%) yet competing interests exist.
  • Transposon Activation Mutagenesis As a Screening Tool for Identifying

    Transposon Activation Mutagenesis As a Screening Tool for Identifying

    Chen et al. BMC Cancer 2013, 13:93 http://www.biomedcentral.com/1471-2407/13/93 RESEARCH ARTICLE Open Access Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics Li Chen1,2*, Lynda Stuart2, Toshiro K Ohsumi3, Shawn Burgess4, Gaurav K Varshney4, Anahita Dastur1, Mark Borowsky3, Cyril Benes1, Adam Lacy-Hulbert2 and Emmett V Schmidt2 Abstract Background: The development of resistance to chemotherapies represents a significant barrier to successful cancer treatment. Resistance mechanisms are complex, can involve diverse and often unexpected cellular processes, and can vary with both the underlying genetic lesion and the origin or type of tumor. For these reasons developing experimental strategies that could be used to understand, identify and predict mechanisms of resistance in different malignant cells would be a major advance. Methods: Here we describe a gain-of-function forward genetic approach for identifying mechanisms of resistance. This approach uses a modified piggyBac transposon to generate libraries of mutagenized cells, each containing transposon insertions that randomly activate nearby gene expression. Genes of interest are identified using next- gen high-throughput sequencing and barcode multiplexing is used to reduce experimental cost. Results: Using this approach we successfully identify genes involved in paclitaxel resistance in a variety of cancer cell lines, including the multidrug transporter ABCB1, a previously identified major paclitaxel resistance gene. Analysis of co-occurring transposons integration sites in single cell clone allows for the identification of genes that might act cooperatively to produce drug resistance a level of information not accessible using RNAi or ORF expression screening approaches. Conclusion: We have developed a powerful pipeline to systematically discover drug resistance in mammalian cells in vitro.